USP Medicare Model Guidelines v6.0 (Categories and Classes)

Similar documents
WESTCHESTER COMMUNITY COLLEGE Valhalla, NY COURSE TITLE: Pharmacology (for Nursing and Health Fields) COURSE NUMBER: Biology 202

Illinois Department of Revenue Regulations TITLE 86: REVENUE CHAPTER I: DEPARTMENT OF REVENUE

Pharmacology 260 Online Course Schedule Spring 2012

BAPTIST HEALTH MEDICATION EXAMINATION INFORMATION SHEET

GPI CLASSIFICATION REPORT

1. The potential sites of action for sympathomimetics and the difference between a direct and indirect acting agonist.

Contra Costa Regional Medical Center and Health Centers

Health Careers. Course Syllabus and Outline. PHARMACOLOGY FOR NURSES Nursing 220 ONLINE COURSE

PROFESSIONAL BOARD FOR EMERGENCY CARE

Pharmacology - Problem Drill 06: Autonomic Pharmacology - Adrenergic System

MEDICARE MODERNIZATION ACT FINAL GUIDELINES -- FORMULARIES CMS

HEdis Code Quick Reference Guide Disease Management Services

Good Review Practice. October 2009 Labeling

Herbal Remedies and Prescription Medications

NAP 117 MEDICATION ASSISTANT COURSE

Anatomical Therapeutic Chemical (ATC) classification and the Defined Daily Dose (DDD): principles for classifying and quantifying drug use

PHARM 726. FUNDAMENTAL PHARMACOLOGY

Drug Treatment in Gynaecology Second edition

Healthcare Effectiveness Data and Information Set (HEDIS ) Guide

ICD 9 to ICD 10 Code Conversions Based on 2014 GEMs Alcohol and Drug Abuse Programs Approved ICD 10 Codes 3/21/2014

Hormones & Chemical Signaling

Drugs, The Brain, and Behavior

MEDICATION AND LABORATORY MONITORING

Introduction to Animal Systems

Chapter 28. Drug Treatment of Parkinson s Disease

The Testosterone Report

Treatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are:

COURSE SYLLABUS DH340-3 Pharmacology & Pain Control

Drug Use Among Seniors on Public Drug Programs in Canada, 2012

Handbook for Community Pharmacy Practice

OGB PELICAN HSA 775 COMPREHENSIVE CDHP MEDICAL BENEFIT PLAN SCHEDULE OF BENEFITS

Pharmacological CLASSIFICATION OF DRUGS. with Doses and Preparations

Social phobia following maprotiline: The first case report. Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran

Clock Hours I General Concepts of Pharmacy III Pharmacy Billing, Repacking and Compounding

Functional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE

ADRENERGIC RECEPTOR AGONIST,CLASSIFICATION AND MECHANISM OF ACTION.

Chapter 20 USE OF DRUGS FOR NEUROLOGICAL DISORDER

Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma

Adrenergic receptors lec 9, part 2. 16/10/2014 Dr. Laila M. Matalqah Rama Kamal Ali Treany

Prescribed Drug Spending in Canada, 2013: A Focus on Public Drug Programs

Milwaukee School of Engineering Case Study: Factors that Affect Blood Pressure Instructor Version

ORGANIC MEDICINAL AND PHARMACEUTICAL CHEMISTRY

Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth

Depression is a common biological brain disorder and occurs in 7-12% of all individuals over

Column1 Substance Abuse Diagnosis Exclusion Codes ICD-9: Description Alcohol withdrawal delirium Alcohol-induced persisting amnestic

Excerpt from Food-Medication Interactions 13th edition by Zaneta M. Pronsky, MS, RD, LDN, FADA INTRODUCTION

Why Meditation is successful in Substance abuse treatment. Mediation paired with substance abuse treatment has been around since 1982 when the

Managing Chronic Pain in Adults with Substance Use Disorders

Research Article Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India

Perioperative Medication Management

Chapter 20: Antimicrobial Drugs

DRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A TERTIARY CARE HOSPITAL

MA 2000 Pharmacology for Medical Assistants

Hormonal Cycles. 1. Briefly describe each component of an endocrine feedback loop: Stimulus. Production Cell. Hormone. Target Cell. Target Cell Action

Chronic Kidney Disease and Diabetes

ORGAN SYSTEMS OF THE BODY

Chapter 4. The Adrenal Medulla

ACOEM Commercial Driver Medical Examiner Training Program. Module 8: Drug Abuse & Alcoholism, Medication Use

Preventive Care Recommendations THE BASIC FACTS

Data Based Medicine Paper: Dependence and Withdrawal

Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation

Administering Medications

The Endocrine System

Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions

Key Points. Autonomic Nervous System Drugs. Autonomic effects Sympathetic. Drugs can modify ANS activity by: Autonomic Nervous System

BSc in Medical Sciences with PHARMACOLOGY

Sponsored by: 2013 NAMI Maryland Conference Baltimore, Maryland; Friday, October 18 th, 2013

Endocrine System: Practice Questions #1

POPULAR DEPRESSION MEDICATIONS

Endocrine Responses to Resistance Exercise

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

PHC 313 The 7 th. Lecture. Adrenergic Agents

Medications for chronic pain

MEASURING CARE QUALITY

Coding and Payment Guide for Laboratory Services. An essential coding, billing, and payment resource for laboratory and pathology services

KEY CHAPTER 14: BLOOD OBJECTIVES. 1. Describe blood according to its tissue type and major functions.

Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program

Urinary System. And Adrenal Function

Shared Care Agreement Insulin Degludec (Tresiba )

Prescribed Drug Spending in Canada, 2012: A Focus on Public Drug Programs

SECTION N: MEDICATIONS. N0300: Injections. Item Rationale Health-related Quality of Life. Planning for Care. Steps for Assessment. Coding Instructions

regulation of ECF composition and volume regulation of metabolism thyroid hormones, epinephrine, growth hormone, insulin and glucagon

NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Vitamin D and Bone Health CE APPLICATION FORM

EXECUTIVE BLOOD WORK PANEL

Transcription:

USP Medicare Model Guidelines v6.0 (Categories and Classes) USP Category Analgesics Nonsteroidal Anti-inflammatory Drugs Opioid Analgesics, Long-acting Opioid Analgesics, Short-acting Anesthetics Local Anesthetics Anti-Addiction/ Substance Abuse Treatment Agents Alcohol Deterrents/Anti-craving Opioid Dependence Treatments Opioid Reversal Agents Smoking Cessation Agents Antibacterials Aminoglycosides Beta-lactam, Cephalosporins Beta-lactam, Penicillins Beta-lactam, Other

Macrolides Quinolones Sulfonamides Tetracyclines Antibacterials, Other Anticonvulsants Calcium Channel Modifying Agents Gamma-aminobutyric Acid (GABA) Augmenting Agents Glutamate Reducing Agents Sodium Channel Agents Anticonvulsants, Other Antidementia Agents Cholinesterase Inhibitors N-methyl-D-aspartate (NMDA) Receptor Antagonist Antidementia Agents, Other Antidepressants Monoamine Oxidase Inhibitors

SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors) Tricyclics Antidepressants, Other Antiemetics Emetogenic Therapy Adjuncts Antiemetics, Other Antifungals Antigout Agents Anti-inflammatory Agents Glucocorticoids Nonsteroidal Anti-inflammatory Drugs Antimigraine Agents Ergot Alkaloids Serotonin (5-HT) 1b/1d Receptor Agonists Prophylactic Antimyasthenic Agents

Parasympathomimetics Antimycobacterials Antituberculars Antimycobacterials, Other Antineoplastics Alkylating Agents Antiandrogens Antiangiogenic Agents Antiestrogens/Modifiers Antimetabolites Aromatase Inhibitors, 3rd Generation Enzyme Inhibitors Molecular Target Inhibitors Monoclonal Antibodies Retinoids Antineoplastics, Other Antiparasitics

Anthelmintics Antiprotozoals Pediculicides/Scabicides Antiparkinson Agents Anticholinergics Dopamine Agonists Dopamine Precursors/ L-Amino Acid Decarboxylase Inhibitors Monoamine Oxidase B (MAO-B) Inhibitors Antiparkinson Agents, Other Antipsychotics 1st Generation/Typical 2nd Generation/Atypical Treatment-Resistant Antispasticity Agents Antivirals Anti-cytomegalovirus (CMV) Agents Anti-hepatitis B (HBV) Agents

Anti-hepatitis C (HCV) Agents Antiherpetic Agents Anti-HIV Agents, Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI) Anti-HIV Agents, Protease Inhibitors Anti-HIV Agents, Integrase Inhibitors (INSTI) Anti-HIV Agents, Other Anti-influenza Agents Anxiolytics SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors) Benzodiazepines Anxiolytics, Other Bipolar Agents Mood Stabilizers Bipolar Agents, Other

Blood Glucose Regulators Antidiabetic Agents Glycemic Agents Insulins Blood Products/Modifiers/ Volume Expanders Anticoagulants Blood Formation Modifiers Coagulants Platelet Modifying Agents Cardiovascular Agents Alpha-adrenergic Agonists Alpha-adrenergic Blocking Agents Angiotensin-converting Enzyme (ACE) Inhibitors Angiotensin II Receptor Antagonists Antiarrhythmics Beta-adrenergic Blocking Agents Calcium Channel Blocking Agents

Diuretics, Carbonic Anhydrase Inhibitors Diuretics, Loop Diuretics, Potassium-sparing Diuretics, Thiazide Dyslipidemics, Fibric Acid Derivatives Dyslipidemics, HMG CoA Reductase Inhibitors Dyslipidemics, Other Vasodilators, Direct-acting Arterial Vasodilators, Direct-acting Arterial/Venous Cardiovascular Agents, Other Central Nervous System Agents Attention Deficit Hyperactivity Disorder Agents, Amphetamines Attention Deficit Hyperactivity Disorder Agents, Nonamphetamines Fibromyalgia Agents Multiple Sclerosis Agents Central Nervous System, Other Dental and Oral Agents

Dermatological Agents Enzyme Replacement/ Modifiers Gastrointestinal Agents Antispasmodics, Gastrointestinal Histamine2 (H2) Receptor Antagonists Irritable Bowel Syndrome Agents Laxatives Protectants Proton Pump Inhibitors Gastrointestinal Agents, Other Genitourinary Agents Antispasmodics, Urinary Benign Prostatic Hypertrophy Agents Phosphate Binders Genitourinary Agents, Other Hormonal Agents, Stimulant/ Replacement/ Modifying (Adrenal)

Hormonal Agents, Stimulant/Replacement/ Modifying (Pituitary) Hormonal Agents, Stimulant/ Replacement/ Modifying (Prostaglandins) Hormonal Agents, Stimulant/ Replacement/ Modifying (Sex Hormones/ Modifiers) Anabolic Steroids Androgens Estrogens Progesterone Agonists/Antagonists Progestins Selective Estrogen Receptor Modifying Agents Hormonal Agents, Stimulant/Replacement/ Modifying (Thyroid) Hormonal Agents, Suppressant (Adrenal) Hormonal Agents, Suppressant (Parathyroid) Hormonal Agents, Suppressant (Pituitary) Hormonal Agents, Suppressant (Thyroid)

Antithyroid Agents Immunological Agents Angioedema (HAE) Agents Immune Suppressants Immunizing Agents, Passive Immunomodulators Vaccines Inflammatory Bowel Disease Agents Glucocorticoids Aminosalicylates Sulfonamides Metabolic Bone Disease Agents Ophthalmic Agents Ophthalmic Anti-allergy Agents Ophthalmic Antiglaucoma Agents Ophthalmic Anti-inflammatories Ophthalmic Prostaglandin and Prostamide Analogs

Ophthalmic Agents, Other Otic Agents Respiratory Tract/ Pulmonary Agents Antihistamines Anti-inflammatories, Inhaled Corticosteroids Antileukotrienes Bronchodilators, Anticholinergic Bronchodilators, Sympathomimetic Cystic Fibrosis Agents Mast Cell Stabilizers Phosphodiesterase Inhibitors, Airways Disease Pulmonary Antihypertensives Respiratory Tract Agents, Other Skeletal Muscle Relaxants Sleep Disorder Agents GABA Receptor Modulators Sleep Disorders, Other

Therapeutic Nutrients/ Minerals/ Electrolytes Electrolyte/Mineral Modifiers Electrolyte/Mineral Replacement Vitamins